Drug intelligence / Profile preview

gentamicin + cefazolin

Development stage
Unknown
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Gentamicin + cefazolin is a combination of two antibiotics used together for their synergistic antibacterial effects. Gentamicin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to cell death. Cefazolin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, resulting in cell lysis and death. The combination has been shown to be synergistic against certain bacteria, including enterococci and Escherichia coli, making it useful in treating severe infections where broad-spectrum coverage or enhanced efficacy is needed[1][2][9]. This combination has been studied for use in surgical prophylaxis (such as cardiac surgery), prevention of infection in open fractures, and treatment of serious infections when monotherapy may be insufficient[4][8]. Both drugs are administered parenterally.

Other names
Gentamicin and cefazolin
02

Targets

PBP (Penicillin-binding protein family)30S A-site (Bacterial ribosomal 30S A-site)

Beyond the preview

Go deeper on gentamicin + cefazolin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gentamicin + cefazolin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call